New suite marks entry into lentiviral vector production and demonstrates the platform’s ability to rapidly expand into new modalities and markets 64x Bio, a biotech company developing scalable ...
SAN FRANCISCO, June 29, 2026--(BUSINESS WIRE)--64x Bio, a biotech company developing scalable solutions for the production of advanced therapies, today announced the launch of LV Apex Suite, a new ...
64x Bio, a biotech company developing scalable solutions for the production of advanced therapies, today announced the launch of LV Apex Suite, a new product line designed to support high performance ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results